Literature DB >> 26671408

Determinants and Prognostic Significance of Hematoma Sedimentation Levels in Acute Intracerebral Hemorrhage.

Shoichiro Sato1, Candice Delcourt, Shihong Zhang, Hisatomi Arima, Emma Heeley, Danni Zheng, Rustam Al-Shahi Salman, Christian Stapf, Christophe Tzourio, Thompson Robinson, Richard I Lindley, John Chalmers, Craig S Anderson.   

Abstract

BACKGROUND: This study aimed at identifying the determinants and prognostic significance of a sedimentation level (fluid-blood level) in the hematoma among patients with acute intracerebral hemorrhage (ICH) who participated in the main Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT2).
METHODS: Post-hoc analysis of the INTERACT2 dataset, a randomized controlled trial of patients with acute ICH with elevated systolic blood pressure (SBP), randomly assigned to intensive (target SBP <140 mm Hg) or guideline-based (<180 mm Hg) BP management. Patients with a sedimentation level at baseline assessment on CT, and modified Rankin Scale score at 90-day, were included in these analyses. Factors associated with a sedimentation level and its significance in relation to 90-day clinical outcomes were assessed in univariable and multivariable logistic regression models.
RESULTS: Of 2,065 participants, 19 (1%) had sedimentation level on baseline CT, which was independently associated with warfarin use (p = 0.006) and lobar ICH (p = 0.025). Sedimentation level was also associated with death or major disability at 90-day in both crude (84 vs. 53%; p = 0.014) and multivariable analyses adjusted for age, gender, Chinese region, warfarin use, baseline National Institutes of Health Stroke Scale score, onset to CT time, volume and location of ICH, intraventricular extension, and randomized intensive BP lowering (OR 3.94, 95% CI 1.01-15.37; p = 0.049).
CONCLUSIONS: The presence of hematoma sedimentation level on baseline CT is associated with warfarin use and lobar location of ICH, and predicts a worse outcome. Although uncommon, sedimentation level is an easily detectable prognostic factor in acute ICH.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26671408     DOI: 10.1159/000442532

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  6 in total

1.  Refining Prognosis for Intracerebral Hemorrhage by Early Reassessment.

Authors:  Matthew B Maas; Brandon A Francis; Rajbeer S Sangha; Bryan D Lizza; Eric M Liotta; Andrew M Naidech
Journal:  Cerebrovasc Dis       Date:  2017-01-04       Impact factor: 2.762

Review 2.  Computed Tomography Imaging Predictors of Intracerebral Hemorrhage Expansion.

Authors:  Xin-Ni Lv; Lan Deng; Wen-Song Yang; Xiao Wei; Qi Li
Journal:  Curr Neurol Neurosci Rep       Date:  2021-03-12       Impact factor: 5.081

Review 3.  Noncontrast Computed Tomography Markers of Intracerebral Hemorrhage Expansion.

Authors:  Gregoire Boulouis; Andrea Morotti; Andreas Charidimou; Dar Dowlatshahi; Joshua N Goldstein
Journal:  Stroke       Date:  2017-03-13       Impact factor: 7.914

4.  Fluid-Blood Level and Hematoma Expansion in a Cerebral Amyloid Angiopathy-Associated Intracerebral Hematoma.

Authors:  Ryoichi Suzuki; Tomohiro Yamasaki; Shinichiro Koizumi; Takao Nozaki; Hisaya Hiramatsu; Tetsuro Sameshima; Kenji Sugiyama; Hiroki Namba
Journal:  Am J Case Rep       Date:  2019-06-15

Review 5.  Hyperacute prediction of functional outcome in spontaneous intracerebral haemorrhage: systematic review and meta-analysis.

Authors:  Ulrike Hammerbeck; Aziza Abdulle; Calvin Heal; Adrian R Parry-Jones
Journal:  Eur Stroke J       Date:  2022-02-17

6.  Admission computed tomography radiomic signatures outperform hematoma volume in predicting baseline clinical severity and functional outcome in the ATACH-2 trial intracerebral hemorrhage population.

Authors:  Stefan P Haider; Adnan I Qureshi; Abhi Jain; Hishan Tharmaseelan; Elisa R Berson; Tal Zeevi; Shahram Majidi; Christopher G Filippi; Simon Iseke; Moritz Gross; Julian N Acosta; Ajay Malhotra; Jennifer A Kim; Lauren H Sansing; Guido J Falcone; Kevin N Sheth; Seyedmehdi Payabvash
Journal:  Eur J Neurol       Date:  2021-07-18       Impact factor: 6.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.